Deadline for submission of applications: 01/06/2018

Reference: 13/2018

Number of vacancies: 1

Offer description:

VHIO´s Cancer Genomics Group serves as a Core Technology laboratory and is also dedicated to translational research, novel genomic test development and collaborating in early clinical studies with molecular targeted agents. At any given time, around 30 early phase trials are conducted with novel agents under study to  target a broad spectrum of cancer genes and pathways. Our Lab is equipped with an n-Counter platform (Nanostring), digital droplet PCR (BEAMing and Bio-Rad), a MiSeq and a HiSeq 2500 (Illumina) sequencers and hardware.

We are seeking a laboratory technician to work in nucleic acid extraction of fresh/frozen and FFPE samples, library preparation for sequencing technologies, ddPCR, qPCR and RT-qPCR, etc.,as well as assist in developing  new applications in NGS for the molecular profiling of  cancer patients.

Conditions:

  • Full-time, 1 year contract with good prospects for renewal.
  • Estimated annual gross salary: according to profile and experience.
  • Start date: July 1st, 2018.

Requirements:

  • Experience: At least 4 years’  relevant laboratory experience in molecular biology techniques. Experience in genomics will be favorably considered.
  • Studies: Applicants should hold a PhD, BSc or MSc.
  • Languages: fluency in English is required.
  • Computer literacy is essential.

About VHIO:

Under the leadership of Josep Tabernero, the Vall d’Hebron Institute of Oncology (VHIO), created by José Baselga in 2006, has established itself as a comprehensive cancer center of proven excellence internationally. It is thanks to Josep’s directorship and VHIO´s optimal organizational structure based on a purely multidisciplinary and translational model that VHIO talents continue to anticipate and tackle the many unresolved questions in combatting this multifaceted and heterogeneous disease.

Located within the Vall d´Hebron Barcelona Hospital Campus, our researchers closely collaborate and interact with Vall d´Hebron physician-scientists. Translational science and clinical research are therefore tightly connected which promotes superb interaction and teamwork which, in turn, accelerates the bench-bedside-bed cycle of knowledge. This privileged environment affords VHIO direct access to patients as well as the entire spectrum of oncology professionals who care for them, and a second-to-none appreciation of how cancer science can translate into more powerful, targeted treatments and better practice for the care of patients.

VHIO´s pioneering model and programs, coupled with its belief in combining strengths through cross-border collaborations, continue to spur advances in reversing cancer resistance, halting metastatic spread, and more effectively treating even the most undruggable tumor types.

VHIO´s translation toward precision oncology: http://www.vhio.net

Where to apply:

Please send a CV and cover letter to selecciorrhh@vhio.net